BUY
Score-1.00
View →
- Total posts
- 1844
- Total predictions
- 835
- Success rate
- 36.5%
- Avg score
- -0.21
POST
Updates for Getting Payment on the Sun Communities ($SUI) $2.3M Settlement
https://preview.redd.it/89ca7oi3ledh1.png?width=1779&format=png&auto=webp&s=6e2cdafc9f8866214eafad9d0fac4d1600c367ab Hey guys, just a heads up Sun Communities agreed to a $2.3 million settlement over claims it misled investors about insider loans, corporate governance, and financial reporting. I recently found out they're still reviewing late claims. The case came …
POST
SMX !!!!! Up 18%
[deleted]
TARG
COSM Share Buyback convert to DH shares less shares to cover?
COSM By now you should be aware of the situation here Insiders own a boat load of shares and company is currently doing an open market share buyback on a daily basis. Bullish press releases and has has until December …
POST
$AIMN News
# Aimwell Partners Inc. (OTC:AIMN) Confirms Advanced Discussions With Curated Life Sciences Capital Network **MIAMI, FL /** [**ACCESS Newswire**](https://www.accessnewswire.com/) **/ July 15, 2026 /** Aimwell Partners Inc. (OTCID:AIMN), parent company of AimwellBio, today confirmed it is engaged in advanced discussions …
POST
MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer’s Disease and Dementia
Get in while you can. Business is breakeven on its own without this result and current price essentially gives this result for free. IMO, a double or triple from here but go ahead and ask your AI friend of choice …
BUY
Fractyl Health (GUTS) Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation
Up to 84% of GLP-1 induced weight loss retained with Revita® versus 46% with sham at one year in patients receiving complete duodenal ablations Next anticipated Revita® milestones are topline six-month randomized data from the REMAIN-1 Pivotal Cohort in early …
Score-1.00
View →
BUY
embecta- EMBC ✅
**But there is also some positive news.** At the end of the article, they themselves list several factors that could support Embecta: partnerships with more than **30 pharmaceutical companies**; joint projects related to **GLP-1 and pen needles**; emerging markets; cost …
Score1.00
View →
POST
[ Removed by moderator ]
[removed]
BUY
VYNE THERAPEUTICS CASH DIVIDEND
NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company") today announced that its Board of Directors has declared a special cash dividend (the "Cash Dividend") in connection with the previously announced merger …
Score1.00
View →